MarketsandMarkets is proud to announce the 3rd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress to be held on October 22-23, 2020 in Boston, USA.
While the 2nd annual Congress had discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation, the 3rd Annual will focus on how the insights derived from real world data, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators, doctors, and payers.
Click here to see the post-show report of our 2nd Edition of the congress.
Learn how the adoption of real-world evidence can be accelerated across the pharmaceutical industry
Explore capabilities of using Artificial Intelligence & Machine Learning in taming scientific research
Understand the impact of innovative real-world evidence partnerships for better data
Our aim for the 3rd Annual Real-World Data and Life Science Analytics Congress is to unite all stakeholders to see how to use conventional informational indexes and layer that in with innovative analytical techniques and new working models.
From Pharmaceutical and Biopharmaceutical companies